Virtual Medicinal Product (VMP) - Co-amoxiclav 250mg/62mg/5ml oral suspension
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Co-amoxiclav 250mg/62mg/5ml oral suspension | Start Date 18-11-2004 | End Date |
| Previous Name | Previous Name Co-amoxiclav 250mg/62mg oral suspension | Start Date 04-05-2004 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 5.0
- UDFS UOM
- ml
- Unit Dose UOM
- spoonful
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Non-availability Indicator
- Actual Products Available
- Name Basis
- BAN - British Approved Name
Codes
- ATC Code
- J01CR02
| BNF | Start Date | End Date |
|---|---|---|
| Current BNF 05010103 | Start Date 04-04-2022 | End Date |
| Previous BNF 05010103 | Start Date 01-02-2005 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 7322311000001107 | 02-04-2004 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Amoxicillin trihydrate | Based on Base Substance | Amoxicillin | 50 mg | 1 ml |
| Potassium clavulanate | Based on Base Substance | Clavulanic acid | 12.5 mg | 1 ml |
Name
Amoxicillin trihydrate
Basis of strength description
Based on Base Substance
BOSS
Amoxicillin
Strength and UOM (Nmr)
50.0
Strength and UOM (Dmr)
1.0
Name
Potassium clavulanate
Basis of strength description
Based on Base Substance
BOSS
Clavulanic acid
Strength and UOM (Nmr)
12.5
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMCo-amoxiclav
-
VMP(Current) Co-amoxiclav 250mg/62mg/5ml oral sus...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 100 ml | 360 | Part VIIIA Category C |